Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ana Maria Popa
Observed names:
ANA MARIA POPA,
Ana Maria POPA,
Ana Popa,
Ana-Maria POPA,
Ana-Maria Popa,
Popa, Ana
show all 6
Institutions:
Carol Davila University of Medicine and Pharmacy,
Spitalul Universitar de Urgență Elias
Observed institutions:
Carol Davila University of Medicine and Pharmacy,
Spitalul Universitar de Urgență Elias,
Nicolae Testemițanu State University of Medicine and Pharmacy,
Institutul Clinic Fundeni
ORCID:
0000-0002-3784-5010
Observed ORCID:
0000-0002-3784-5010
OpenAlex ID:
A5113941673
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
2023
·
Ioana-Miruna Stanciu
, Andreea Ioana Parosanu
, et al.
·
Diagnostics
·
51
PDF
Update on radionuclide therapy in oncology (Review)
2017
·
Cornelia Nitipir
, Dana Niculae
, et al.
·
Oncology Letters
·
37
PDF
The Impact of Long-Term Antibiotic Therapy of Cutaneous Adverse Reactions to EGFR Inhibitors in Colorectal Cancer Patients
2021
·
Mara Mădălina Mihai
, Ana Ion
, et al.
·
Journal of Clinical Medicine
·
25
PDF
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma
2023
·
Andreea Ioana Parosanu
, Cristina Florina Pirlog
, et al.
·
Current Oncology
·
19
PDF
The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis
2023
·
Radu Andrei Emilescu
, Mariana Jinga
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature Review
2023
·
Ioana-Miruna Stanciu
, Cristina Florina Pirlog
, et al.
·
Medicina
·
9
PDF
Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature
2022
·
Cristina-Florina Pîrlog
, Andreea Ioana Paroșanu
, et al.
·
Current Oncology
·
9
PDF
Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer
2022
·
Cristina-Florina Pirlog
, Horia Teodor Cotan
, et al.
·
Cureus
·
7
PDF
The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer
2021
·
Maria Cristina Orlov-Slavu
, Ana Maria Popa
, et al.
·
Cureus
·
6
PDF
The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer
2024
·
Alexandra Lazar
, Ana Maria Popa
, et al.
·
Medicina
·
4
Second Primary Lung Cancer after Breast Cancer: Challenges and Approaches
2023
·
BOGHICI Elena-Monica
, Andreea-Ioana PAROSANU
, et al.
·
Medicina Moderna - Modern Medicine
·
4
PDF
Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?
2023
·
Cristina-Florina Pîrlog
, Raluca Costache
, et al.
·
Diagnostics
·
4
PDF
Infection and reinfection with SARS‑CoV‑2 in cancer patients: A cohort study
2022
·
Cornelia Nitipir
, Andreea Parosanu
, et al.
·
Experimental and Therapeutic Medicine
·
4
PDF
Dysplastic nevus syndrome and pancreatic cancer: A case report
2021
·
Liliana Popa
, Calin Giurcaneanu
, et al.
·
Experimental and Therapeutic Medicine
·
4
PDF
Type II Diabetes Mellitus - Associated Risk Factor in the Onset and Evolution of Digestive Tract Carcinoma
2019
·
CORNELIA NITIPIR
, MARIA ALEXANDRA BARBU
, et al.
·
ROMANIAN BIOTECHNOLOGICAL LETTERS
·
4
PDF
Is adjuvant hysterectomy an option after radio-chemotherapy for locally advanced cervical cancer? A review
2018
·
Cornelia Nitipir
, Cristina Orlov
, et al.
·
Journal of Clinical and Investigative Surgery
·
4
PDF
Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania
2023
·
Ana Maria Popa
, Mihaela Andreea Stejeroiu
, et al.
·
Cureus
·
3
PDF
News in Cancer-Related Pain Management
2020
·
Cornelia NITIPIR
, Andreea PAROSANU
, et al.
·
Medicina Moderna - Modern Medicine
·
2
PDF
The Importance of Dose Intensity When Administering Cytotoxic Chemotherapy in NSCLC—A Matter as Actual Now as in the Past
2020
·
Cornelia Nitipir
, Cristina Orlov-Slavu
, et al.
·
Processes
·
2
PDF
New biomolecules for the treatment of Disseminated Intravascular Coagulation
2019
·
CORNELIA NITIPIR
, ANA MARIA NEAGU
, et al.
·
ROMANIAN BIOTECHNOLOGICAL LETTERS
·
2
PDF
Correction: Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania
2025
·
Ana Maria Popa
, Mihaela Andreea Stejeroiu
, et al.
·
Cureus
·
1
The Impact of BRCA Mutation on the Efficacy of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
2024
·
Ana Maria Popa
, Horia Teodor Cotan
, et al.
·
Chirurgia
·
1
PDF
The Role of Multigene Assays in Adjuvant Treatment Decision for Early-Stage Breast
2020
·
Cornelia NITIPIR
, Andreea PAROSANU
, et al.
·
Medicina Moderna - Modern Medicine
·
1
Important Aspects to Take Into Consideration When Administering Cytotoxic Chemotherapy. A Review
2017
·
Cornelia Nitipir
, Ana-Maria Popa
, et al.
·
Medicina Moderna - Modern Medicine
·
1
PDF
Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy
2022
·
Andreea Parosanu
, Ioana Miruna Stanciu
, et al.
·
Cureus
PDF
Show more works
View as search
Works count:
31
Citation count:
215
H-index:
7
I10-index:
5
Year
Topic
Type